Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study
ConclusionThe serum concentration of PCZ was related to the incidence of IFIs and a serum concentration of >0.47 μg/ml is highly recommended to avoid IFIs after chemotherapy or HSCT.Clinical Trial RegistrationChinese Clinical Trial Registry: ChiCTR1900026294.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
More News: Cancer & Oncology | Chemotherapy | China Health | Clinical Trials | Fungal Infections | Hematology | Microbiology | Proton Pump Inhibitors PPIs | Stem Cell Therapy | Stem Cells | Study | Transplants